Abstract
Although much of medicine is focused on the increased aging of the population,
children still represent the bulk the dependent population worldwide.
Important regulatory factors are at work in the pediatric pharmaceutical
market. The recognition of the rights of children to have access to safe and
effective drugs and the needs of healthcare providers to have access to
age-appropriate drug information continues to have a major effect on all areas
of pediatric pharmaceuticals including pediatric biomedical research.
Pediatric Drugs, the Worldwide Market is the completely updated edition of
Kalorama Information' s 2005 study on prescription pediatric drugs focuses
on the following treatment segments:
- Allergy and Respiratory Drugs
- Anti-Infectives
- Cancer Therapies
- Cardiovascular Drugs
- Central Nervous System Drugs
- Gastrointestinal Drugs
- Hormone Drugs
- Other Pediatric Drugs
The 500-page report includes global statistical information for conditions and
diseases affecting pediatric populations, including detailed discussions and
over 180 exhibits.
Each segment provides an
- Overview,
- Descriptions of products on the market,
- Market estimates and forecasts (U.S. and non-U.S.), and
- Competitive analysis of leading providers including market share
In addition, the report includes extensive tables of products in research and
development and approved prescription drugs for which additional pediatric
information may produce health benefits in the pediatric population. There are
also in-depth discussions of current issues and trends affecting the industry
and what trends may arise in the future.
The research conducted by Kalorama Information included comprehensive research
of secondary sources such as company literature, databases, investment
reports, and medical and business journals. Person-to-person and telephone
interviews were the primary method of gathering information. Interviews with
over 100 key industry officials, consultants, health care providers, and
government personnel were complied to form the primary basis of
information-specifically revenue and market share data-presented in this
report. Specific interviews with pharmaceutical company representatives
included marketing directors, division managers, and product representatives.
All market data pertain to the world market at the manufacturers' level. The
base year for data was 2006. Historical data are provided for 2004 and 2005
with forecast data provided for 2007 through 2011. Compound annual growth
rates (CAGRs) are provided for the 2004-2006, 2006-2011, and 2004-2011 periods
for each industry segment covered.
| 
View Cart
